INNOVA CAPTAB
|
INNOVA CAPTAB Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹57 Cr | ₹57 Cr | ₹48 Cr | ₹12 Cr | ₹12 Cr |
Equity - Authorised | ₹64 Cr | ₹64 Cr | ₹64 Cr | ₹12 Cr | ₹12 Cr |
Equity - Issued | ₹57 Cr | ₹57 Cr | ₹48 Cr | ₹12 Cr | ₹12 Cr |
Equity Paid Up | ₹57 Cr | ₹57 Cr | ₹48 Cr | ₹12 Cr | ₹12 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹100.00 | ₹100.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹902 Cr | ₹774 Cr | ₹229 Cr | ₹197 Cr | ₹133 Cr |
Securities Premium | ₹378 Cr | ₹378 Cr | - | - | - |
Capital Reserves | ₹71 Cr | ₹71 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
Profit & Loss Account Balance | ₹453 Cr | ₹325 Cr | ₹228 Cr | ₹197 Cr | ₹133 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹902 Cr | ₹774 Cr | ₹229 Cr | ₹197 Cr | ₹133 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹959 Cr | ₹831 Cr | ₹277 Cr | ₹209 Cr | ₹145 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹244 Cr | ₹208 Cr | ₹62 Cr | ₹40 Cr | ₹6.00 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹270 Cr | ₹218 Cr | ₹65 Cr | ₹51 Cr | ₹12 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-27 Cr | ₹-9.77 Cr | ₹-3.08 Cr | ₹-11 Cr | ₹-5.60 Cr |
Unsecured Loans | - | - | ₹72 Cr | ₹27 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹27 Cr | - |
Other Unsecured Loan | - | - | ₹72 Cr | - | - |
Deferred Tax Assets / Liabilities | ₹0.95 Cr | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr | ₹1.93 Cr |
Deferred Tax Assets | ₹18 Cr | ₹23 Cr | ₹2.35 Cr | ₹1.95 Cr | ₹0.49 Cr |
Deferred Tax Liability | ₹19 Cr | ₹7.92 Cr | ₹6.15 Cr | ₹3.78 Cr | ₹2.41 Cr |
Other Long Term Liabilities | ₹1.35 Cr | ₹2.32 Cr | ₹9.36 Cr | ₹0.68 Cr | ₹0.48 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹9.91 Cr | ₹9.14 Cr | ₹47 Cr | ₹18 Cr | ₹36 Cr |
Total Non-Current Liabilities | ₹256 Cr | ₹205 Cr | ₹194 Cr | ₹88 Cr | ₹44 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹202 Cr | ₹180 Cr | ₹158 Cr | ₹145 Cr | ₹112 Cr |
Sundry Creditors | ₹202 Cr | ₹180 Cr | ₹158 Cr | ₹145 Cr | ₹112 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹77 Cr | ₹58 Cr | ₹21 Cr | ₹28 Cr | ₹69 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹11 Cr | ₹13 Cr | ₹2.47 Cr | ₹3.59 Cr | ₹4.49 Cr |
Interest Accrued But Not Due | ₹1.32 Cr | ₹1.02 Cr | ₹1.21 Cr | ₹0.51 Cr | ₹0.62 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹65 Cr | ₹44 Cr | ₹17 Cr | ₹24 Cr | ₹64 Cr |
Short Term Borrowings | ₹66 Cr | ₹24 Cr | ₹98 Cr | ₹120 Cr | ₹33 Cr |
Secured ST Loans repayable on Demands | ₹65 Cr | ₹23 Cr | ₹97 Cr | ₹98 Cr | ₹26 Cr |
Working Capital Loans- Sec | ₹65 Cr | ₹23 Cr | ₹97 Cr | ₹98 Cr | ₹26 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-64 Cr | ₹-22 Cr | ₹-97 Cr | ₹-76 Cr | ₹-19 Cr |
Short Term Provisions | ₹32 Cr | ₹32 Cr | ₹0.58 Cr | ₹22 Cr | ₹0.53 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹27 Cr | ₹29 Cr | - | ₹22 Cr | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹4.23 Cr | ₹3.06 Cr | ₹0.58 Cr | ₹0.35 Cr | ₹0.53 Cr |
Total Current Liabilities | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr | ₹215 Cr |
Total Liabilities | ₹1,592 Cr | ₹1,329 Cr | ₹748 Cr | ₹612 Cr | ₹404 Cr |
ASSETS | |||||
Gross Block | ₹901 Cr | ₹406 Cr | ₹216 Cr | ₹206 Cr | ₹107 Cr |
Less: Accumulated Depreciation | ₹71 Cr | ₹49 Cr | ₹33 Cr | ₹23 Cr | ₹28 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹830 Cr | ₹358 Cr | ₹183 Cr | ₹183 Cr | ₹79 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹23 Cr | ₹341 Cr | ₹22 Cr | ₹0.03 Cr | ₹7.26 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹6.82 Cr | ₹22 Cr | ₹101 Cr | ₹29 Cr | ₹48 Cr |
Other Non Current Assets | ₹5.85 Cr | ₹0.50 Cr | ₹0.26 Cr | ₹0.28 Cr | - |
Total Non-Current Assets | ₹865 Cr | ₹721 Cr | ₹306 Cr | ₹212 Cr | ₹134 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹208 Cr | ₹144 Cr | ₹117 Cr | ₹128 Cr | ₹91 Cr |
Raw Materials | ₹101 Cr | ₹68 Cr | ₹58 Cr | ₹67 Cr | ₹55 Cr |
Work-in Progress | ₹35 Cr | ₹24 Cr | ₹18 Cr | ₹12 Cr | ₹9.97 Cr |
Finished Goods | ₹11 Cr | ₹5.93 Cr | ₹1.28 Cr | ₹4.52 Cr | ₹9.25 Cr |
Packing Materials | ₹25 Cr | ₹17 Cr | ₹18 Cr | ₹18 Cr | ₹14 Cr |
Stores  and Spare | ₹0.87 Cr | ₹1.27 Cr | ₹0.12 Cr | ₹0.05 Cr | ₹0.19 Cr |
Other Inventory | ₹35 Cr | ₹28 Cr | ₹22 Cr | ₹27 Cr | ₹2.51 Cr |
Sundry Debtors | ₹332 Cr | ₹288 Cr | ₹265 Cr | ₹213 Cr | ₹139 Cr |
Debtors more than Six months | ₹5.23 Cr | ₹9.70 Cr | ₹6.29 Cr | ₹3.32 Cr | ₹2.64 Cr |
Debtors Others | ₹331 Cr | ₹283 Cr | ₹260 Cr | ₹211 Cr | ₹136 Cr |
Cash and Bank | ₹68 Cr | ₹87 Cr | ₹19 Cr | ₹2.44 Cr | ₹12 Cr |
Cash in hand | ₹0.07 Cr | ₹0.05 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.02 Cr |
Balances at Bank | ₹68 Cr | ₹87 Cr | ₹19 Cr | ₹2.43 Cr | ₹7.16 Cr |
Other cash and bank balances | - | - | - | - | ₹4.72 Cr |
Other Current Assets | ₹33 Cr | ₹8.91 Cr | ₹13 Cr | ₹6.41 Cr | ₹2.52 Cr |
Interest accrued on Investments | ₹0.37 Cr | ₹1.24 Cr | ₹0.27 Cr | ₹0.03 Cr | ₹0.63 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹2.77 Cr | ₹3.42 Cr | ₹5.90 Cr | ₹2.07 Cr | ₹0.30 Cr |
Other current_assets | ₹30 Cr | ₹4.25 Cr | ₹7.28 Cr | ₹4.31 Cr | ₹1.59 Cr |
Short Term Loans and Advances | ₹78 Cr | ₹80 Cr | ₹28 Cr | ₹50 Cr | ₹26 Cr |
Advances recoverable in cash or in kind | ₹4.04 Cr | ₹2.79 Cr | ₹1.08 Cr | ₹0.36 Cr | ₹0.88 Cr |
Advance income tax and TDS | ₹23 Cr | ₹28 Cr | - | ₹21 Cr | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹51 Cr | ₹49 Cr | ₹27 Cr | ₹29 Cr | ₹25 Cr |
Total Current Assets | ₹719 Cr | ₹608 Cr | ₹442 Cr | ₹400 Cr | ₹270 Cr |
Net Current Assets (Including Current Investments) | ₹343 Cr | ₹314 Cr | ₹165 Cr | ₹85 Cr | ₹55 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,592 Cr | ₹1,329 Cr | ₹748 Cr | ₹612 Cr | ₹404 Cr |
Contingent Liabilities | - | - | ₹0.06 Cr | ₹0.07 Cr | ₹0.06 Cr |
Total Debt | ₹336 Cr | ₹242 Cr | ₹235 Cr | ₹198 Cr | ₹45 Cr |
Book Value | - | 145.20 | 57.61 | 1,738.38 | 1,206.84 |
Adjusted Book Value | 167.66 | 145.20 | 57.61 | 43.46 | 30.17 |
Compare Balance Sheet of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,315.6 Cr | -0.7% | 1.1% | 35.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | -0.7% |
1.1% |
35.5% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses